Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > onc and preclinical

<< Previous

Bullboard Posts

Next >>

Comment by cleareyeon Sep 20, 2021 10:49am

192 Views

Post# 33886384

RE:onc and preclinical

Inthno,

It appears that we have a company that is content to do research.

In 2003 I was naively more confident of iminent commercialization or buyout or major trial partner than I am now.

I enjoy reading about the science.

I am guilty of riding up and selling, riding down and buying. I am also guilty of lying to myself that I am effective in that sort of trading.

However, yes, I do enjoy the science. And, I sit with a much smaller position than in 2003.

cleareye

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?